Arcadia Biosciences, Inc. — Director's Dealing 2016

Sep 13, 2016

SEC Form 4/A — Form 4/A

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-09-12

Reporting Person: Plavan Matthew T (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.19	2026-09-11	Common Stock (250000)	125000	Direct

Footnotes

F1: This filing is to correct the Exercise Price of the Derivative Security to $2.19 (the previous filing incorrectly reported the Exercise Price as $2.17), and to correct the name of the person signing on behalf of the Reporting Person, to Sherry Mori, as Attorney-in-Fact.

F2: 25% of the total number of shares subject to the option will vest on 9/12/2017; the remaining 75% of the total number of shares subject to the option will vest in 36 equal installments, with the first installment occurring 9/30/2017, and thereafter on the last day of the month for the next 35 months.